S12E20 - Diamidex's CEO Told Me Something Investors Don't Know
Wanna know why Big Pharma is Knocking on This French Startup's Door? Listen to this!
More #water insights? Connect with me on Linkedin: https://www.linkedin.com/in/antoinewalter1/
🙌 Supporters 🙌
A big thank you to my partner SimpleLab: https://link.dww.show/simplelab
And a great shout-out to Blue Foot Membranes: https://link.dww.show/bluefoot
#️⃣ All the Links Mentioned in this Video #️⃣
Diamidex's crowdfunding campaign: https://www.invesdor.com/rounds/0cd04be7-da71-4b8f-be26-6a778d2648dd?utm_campaign=c.diamidex_nr1.ex&utm_source=website&utm_medium=referral#/
The 2022 Nobel Prize they leverage in their technology: https://www.nobelprize.org/uploads/2022/10/press-chemistryprize2022-2.pdf
Diamidex's website: https://diamidex.com/
Connect with Sam on LinkedIn: https://www.linkedin.com/in/sam-dukan/
🎙️ Subscribe and Listen to the Don't Waste Water Podcast HERE 🎙️
Podcast Channel: @dwwpodcast
Main Channel: @AntoineWalterDWW
Smartlink: https://smartlink.ausha.co/dont-waste-water
Website: https://dww.show/podcast/
🙋 QUESTION: What would you like me to cover next?
⏰ TIME CODES ⏰
00:00 In this week's Episode
01:31 Should you invest in Diamidex?
03:34 Technological Breakthroughs in Microbial Detection
11:11 Development Journey and Challenges
20:21 Product Launch and Market Feedback
28:21 Future Prospects and Innovations
32:38 Addressing the Elephant in the Room: Regulation
35:57 Global Adoption and Market Strategies
47:24 Business Model and Revenue Streams
53:56 Future Vision and Growth Strategies
59:33 Rapid Fire Questions and Closing Remarks
📝 IN THIS WEEK'S EPISODE
🔬 How a 10-year journey from CNRS research director to water tech entrepreneur led to a breakthrough that counts microorganisms 4-7x faster than century-old Petri dish methods
🚀 Why this technology delivers results in 6 hours for E. coli instead of 24 hours and 2 days for Legionella instead of 10 days, while maintaining exact regulatory compliance
💡 The secret sauce combining optics, click chemistry (Nobel Prize 2022), and machine learning that makes invisible microbes visible and countable at the micro-colony stage
🏭 How major pharmaceutical and beverage companies are knocking on Diamidex's door, with one global partnership launching end of 2024 and acquisition talks already underway
💰 The razor-blade business model targeting 75-80% recurring revenue from consumables, with equipment potentially given free to high-volume customers, generating €500K annually
Hosted by Ausha. See ausha.co/privacy-policy for more information.
Powered by Ausha 🚀